Ranbaxy wins 2 Lipitor patent cases in Norway

Published on Wed, Aug 30, 2006 at 09:10 |  Source : Moneycontrol.com

Updated at Wed, Aug 30, 2006 at 20:20  

4754 Investors following Pfizer. Share this News with them.
0
0
Share on Tumblr

Excerpts from Power Breakfast on CNBC-TV18 Watch the full show ยป

ALSO READ

Other Stocks in this news

Ranbaxy Laboratories |

Sources suggest that Ranbaxy has won two Lipitor patent cases in Norway. This comes after its partial win in US, reports CNBC-TV18.

The Lipitor market in Norway is pegged at USD 50 million. Ranbaxy had earlier won a Lipitor patent case in US and had lost a patent case to Pfizer .

 

  

Trending News

Business News

Sony to roll-out ICS update next week, Xperia PLAY gets the boot
Reebok execs named in Rs 870 cr fraud denied anticipatory bail "Reebok execs named in Rs 870 cr fraud denied anticipatory bail"

KKR in way of CSK's hat-trick of IPL titles

Rel Comm Q4 Cons Net Revenue Up 5% At `5,310 Cr (QoQ)

The latest earning numbers FIRST on CNBC-TV18
Videos

May 25 2012, 22:26

NHPC posts profit amid capacity addition, delay woes

- in Results Boardroom

Interviews

May 27 2012, 11:52 | Source: CNBC-TV18

Expect to maintain EBIDTA margin ahead: Wockhardt  

May 27 2012, 11:00 | Source: CNBC-TV18

e-commerce market in India: What's in store?  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!